List of insiders holdings for Biohaven Pharmaceutical Holding Co Ltd.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Doogan Declan Director |
2022-02-11 21:44:02 | 0 1,308,989 |
1,308,989 | Form 5 |
| 2 | Coric Vlad Chief Executive Officer |
2022-10-03 20:26:32 | 830,891 0 |
830,891 | Form 4 |
| 3 | Berman Robert Special Projects & Med Ovrsght |
2020-07-10 21:15:52 | 341 790,550 |
790,891 | Form 4 |
| 4 | PORTAGE BIOTECH INC. former 10% owner |
2018-01-25 16:13:45 | 54,494 0 |
54,494 | Form 4/A |
| 5 | AGUIAR ERIC Director |
2020-01-24 18:43:42 | 0 26,250 |
26,250 | Form 4 |
| 6 | Cha Albert Director |
2018-05-03 17:21:23 | 18,000 0 |
18,000 | Form 4 |
| 7 | Repella Robert Director |
2019-05-23 18:37:15 | 18,000 0 |
18,000 | Form 4 |
| 8 | Tilton John Chief Commercial Officer |
2022-10-03 20:27:09 | 1,614 0 |
1,614 | Form 4 |
| 9 | Engelhart James Strategic Advisor |
2022-10-03 20:30:30 | 0 0 |
0 | Form 4 |
| 10 | CHILDS JOHN W Director |
2022-10-03 20:29:12 | 0 0 |
0 | Form 4 |
| 11 | Buten Matthew Chief Financial Officer |
2022-10-03 20:28:30 | 0 0 |
0 | Form 4 |
| 12 | Mehta Kishan Director |
2022-10-03 20:27:51 | 0 0 |
0 | Form 4 |
| 13 | Heffernan Michael Thomas Director |
2022-10-03 20:26:27 | 0 0 |
0 | Form 4 |
| 14 | JONES WILLIAM A JR CCO-Migraine & Common Disease |
2022-10-03 20:25:52 | 0 0 |
0 | Form 4 |
| 15 | GREGORY JULIA P Director |
2022-10-03 20:25:53 | 0 0 |
0 | Form 4 |
| 16 | HUGIN ROBERT J Director |
2022-10-03 20:25:10 | 0 0 |
0 | Form 4 |
| 17 | Antonijevic Irina Director |
2022-10-03 20:25:10 | 0 0 |
0 | Form 4 |
| 18 | Clark George C. VP, Chief Accounting Officer |
2022-10-03 20:24:25 | 0 0 |
0 | Form 4 |
| 19 | Stock Elyse Chief Medical Officer |
2022-10-03 20:23:45 | 0 0 |
0 | Form 4 |
| 20 | Bailey Gregory Director |
2022-10-03 20:23:47 | 0 0 |
0 | Form 4 |
| 21 | Conway Charles Chief Scientific Officer |
2022-10-03 20:23:03 | 0 0 |
0 | Form 4 |
| 22 | Gentile Kimberly SVP, Clinical Operations |
2022-10-03 20:20:09 | 0 0 |
0 | Form 4 |